Drugs / CARBOMER 910
last change Jun 2024 re-read 3 minutes ago

CARBOMER 910

Small molecule

Developed for
dry eye syndrome
Investigated by
Laboratorios Sophia S.A de C.V.

Trials 1

20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT03697876 Aug 2018 → Jun 2024 dry eye syndrome Laboratorios Sophia S.A de C.V. Completed No outcome recorded
Comparator or background therapy2 trials
Phase 2 NCT04785261 Background Mar 2021 → May 2022 dry eye syndrome China Medical University Hospital Unknown No outcome recorded
— NCT06576245 Background Sep 2023 → Feb 2024 dry eye syndrome University of Seville Completed No outcome recorded

Evidence & citations 10 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as CARBOMER 910 ChEMBL registry synonym — accepted as the source's own label CHEMBL2108995 ↗
Known as Blephagel ChEMBL registry synonym — accepted as the source's own label CHEMBL2108995 ↗
Known as Carbomer “Artelac® Nighttime Gel (0.24% Sodium Hyaluronate with Carbomer)” NCT06576245 ↗
2

“Artelac® Nightime Gel. 0.2% Carbomer, ophthalmic gel.” NCT03697876 ↗

NCT04785261 ↗

Known as Carbomer homopolymer ChEMBL registry synonym — accepted as the source's own label CHEMBL2108995 ↗
Known as Carbomere ChEMBL registry synonym — accepted as the source's own label CHEMBL2108995 ↗
Known as Carbomero ChEMBL registry synonym — accepted as the source's own label CHEMBL2108995 ↗
Known as Carbopol ChEMBL registry synonym — accepted as the source's own label CHEMBL2108995 ↗
Known as Carboxypolymethylene ChEMBL registry synonym — accepted as the source's own label CHEMBL2108995 ↗
Modality Small molecule — CHEMBL2108995 ↗
Route Other “in the bottom of the right eye sac” NCT03697876 ↗